Additional Benefits of Serum Oncostatin M Levels Compared to Cardiac Troponin in Non-ST Elevation Myocardial Infarction.

MLA

Akarsu, Murat, et al. “Additional Benefits of Serum Oncostatin M Levels Compared to Cardiac Troponin in Non-ST Elevation Myocardial Infarction.” Acta Cardiologica Sinica, vol. 40, no. 3, May 2024, pp. 281–91. EBSCOhost, https://doi.org/10.6515/ACS.202405_40(3).20240128A.

APA

Akarsu, M., Atıcı, A., Yoldemir, Ş., Özcan, M., Yıldırım, Ö., Akarsu, H., Arman, Y., & Tükek, T. (2024). Additional Benefits of Serum Oncostatin M Levels Compared to Cardiac Troponin in Non-ST Elevation Myocardial Infarction. Acta Cardiologica Sinica, 40(3), 281–291. https://doi.org/10.6515/ACS.202405_40(3).20240128A

Chicago

Akarsu, Murat, Adem Atıcı, Şengül Yoldemir, Mustafa Özcan, Özgür Yıldırım, Harun Akarsu, Yücel Arman, and Tufan Tükek. 2024. “Additional Benefits of Serum Oncostatin M Levels Compared to Cardiac Troponin in Non-ST Elevation Myocardial Infarction.” Acta Cardiologica Sinica 40 (3): 281–91. doi:10.6515/ACS.202405_40(3).20240128A.